# Methylphenidate Hydrochloride Tablet, Extended Release: FDA shortage status

> FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice.

- Derived status: current
- Source statuses: Current
- FDA package records: 34
- Latest FDA row update: 08/19/2026
- Retrieved: 2026-08-22T15:54:11+00:00

## FDA package and manufacturer records

- Janssen Pharmaceuticals — Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01) — FDA availability: Available — updated: 08/19/2026
- Janssen Pharmaceuticals — Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01) — FDA availability: Available — updated: 08/19/2026
- Janssen Pharmaceuticals — Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01) — FDA availability: Available — updated: 08/19/2026
- Janssen Pharmaceuticals — Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01) — FDA availability: Available — updated: 08/19/2026
- Lannett Company, Inc. — Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62175-310-37) — FDA availability: Available — updated: 08/18/2026
- Lannett Company, Inc. — Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62175-311-37) — FDA availability: Available — updated: 08/18/2026
- Lannett Company, Inc. — Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62175-312-37) — FDA availability: Available — updated: 08/18/2026
- Lannett Company, Inc. — Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62175-313-37) — FDA availability: Available — updated: 08/18/2026
- Sun Pharmaceutical Industries, Inc. — Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88) — FDA availability: Unavailable — updated: 08/05/2026
- Sun Pharmaceutical Industries, Inc. — Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88) — FDA availability: Unavailable — updated: 08/05/2026
- Sun Pharmaceutical Industries, Inc. — Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 57664-608-88) — FDA availability: Unavailable — updated: 08/05/2026
- Sun Pharmaceutical Industries, Inc. — Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88) — FDA availability: Unavailable — updated: 08/05/2026
- Teva Pharmaceuticals USA, Inc. — Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01) — FDA availability: Limited Availability — updated: 08/17/2026
- Teva Pharmaceuticals USA, Inc. — Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62037-734-01) — FDA availability: Available — updated: 08/17/2026
- Teva Pharmaceuticals USA, Inc. — Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01) — FDA availability: Limited Availability — updated: 08/17/2026
- Teva Pharmaceuticals USA, Inc. — Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62037-727-01) — FDA availability: Limited Availability — updated: 08/17/2026
- Trigen Laboratories, LLC — Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10) — FDA availability: Limited Availability — updated: 08/17/2026
- Trigen Laboratories, LLC — Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 13811-707-10) — FDA availability: Limited Availability — updated: 08/17/2026
- Trigen Laboratories, LLC — Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 13811-708-10) — FDA availability: Limited Availability — updated: 08/17/2026
- Trigen Laboratories, LLC — Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (NDC 13811-711-30) — FDA availability: Limited Availability — updated: 08/17/2026
- Trigen Laboratories, LLC — Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10) — FDA availability: Limited Availability — updated: 08/17/2026
- Trigen Laboratories, LLC — Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30) — FDA availability: Limited Availability — updated: 08/17/2026
- Trigen Laboratories, LLC — Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30) — FDA availability: Limited Availability — updated: 08/17/2026
- Vertical Pharmaceuticals, LLC — Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10) — FDA availability: Available — updated: 08/17/2026
- Vertical Pharmaceuticals, LLC — Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30) — FDA availability: Available — updated: 08/17/2026
- Vertical Pharmaceuticals, LLC — Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10) — FDA availability: Available — updated: 08/17/2026
- Vertical Pharmaceuticals, LLC — Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-30) — FDA availability: Available — updated: 08/17/2026
- Vertical Pharmaceuticals, LLC — Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10) — FDA availability: Available — updated: 08/17/2026
- Vertical Pharmaceuticals, LLC — Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30) — FDA availability: Available — updated: 08/17/2026
- Vertical Pharmaceuticals, LLC — Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30) — FDA availability: Available — updated: 08/17/2026
- Vertical Pharmaceuticals, LLC — Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10) — FDA availability: Available — updated: 08/17/2026
- Vertical Pharmaceuticals, LLC — Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-30) — FDA availability: Available — updated: 08/17/2026
- Vertical Pharmaceuticals, LLC — Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30) — FDA availability: Available — updated: 08/17/2026
- Vertical Pharmaceuticals, LLC — Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30) — FDA availability: Available — updated: 08/17/2026

## Sources and formats

- [FDA openFDA source](https://api.fda.gov/drug/shortages.json)
- [Canonical HTML](https://citefacts.com/shortages/methylphenidate-hydrochloride-tablet-extended-release)
- [JSON record](https://citefacts.com/shortages/methylphenidate-hydrochloride-tablet-extended-release.json)